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        Plasmacytoid DCs (PDCs) are a rare cell popula-
tion in lymphoid organs that specialize in secret-
ing type I IFNs, i.e. IFN-     /     , in response to 
DNA and RNA viruses. In mice, PDCs were 
initially identifi  ed within the CD11c      DC pop-
ulation as CD11c  low  B220     Gr1     CD11b         cells (  1  ). 
Because classical DCs do not express B220, and 
Gr1 expression on PDCs can be variable, the 
complex PDC phenotype has often been simpli-
fi  ed and PDCs have been identifi  ed in many 
studies as B220     CD11c     CD11b         cells or B220    
CD11c      cells. However, there is increasing 
evidence that B220     CD11c      cells are hetero-
geneous and include more than PDCs. Indeed, 
it was recently found that B220     CD11c      cells 
include a hybrid cell type, which was termed 
IFN-producing killer DCs (IKDCs) (  2, 3  ). 
  IKDCs were shown to display molecular and 
functional characteristics that overlap with those 
of NK cells, PDCs, and DCs. IKDCs express 
NK1.1, lack Gr1, and express MHC class II. As 
NK cells, IKDCs produce IFN-      and kill typical 
NK target cells using NK cell  –  activating recep-
tors. Upon stimulation with CpG oligonucleo-
tides, IKDCs curtail their NK-like activity and 
acquire DC-like antigen-presenting activity 
through up-regulation of MHC class II and 
co-stimulatory molecules. The ability of IKDCs 
to produce IFN-     /      is controversial. In one 
report, IKDCs were found to produce substan-
tial amounts of IFN-      (  3  ). In two other studies, 
secretion of IFN-      was found to be restricted to 
PDCs (  2, 4  ). Thus, it is unclear whether there is 
functional overlap between PDCs and IKDCs. 
The developmental pathway of IKDCs is also 
unclear (  5, 6  ). IKDCs were virtually absent 
in IL-2 receptor       chain  –  defi  cient mice (IL-
2R            /      ) (  3  ). At odds with this report, IKDCs 
were found in mice lacking the common cyto-
kine receptor       chain (     c) (  2  ), which is required 
for IL-2R      signaling. Moreover, IKDCs were 
found to derive from a unique progenitor (  7  ). 
Thus, it is unclear whether IKDCs belong to 
an NK cell or a DC lineage. 
  Because of the constitutive heterogeneity of 
B220     CD11c      cells, the partial overlap of IKDC 
functions with those of PDCs, DCs, and NK 
cells, surface markers that univocally defi  ne dis-
tinct cell types have become essential to dissect 
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  Lymphoid organs contain a B220    CD11c    NK1.1     cell population that was recently charac-
terized as a novel dendritic cell (DC) subset that functionally overlaps with natural killer 
(NK) cells and plasmacytoid DCs (PDCs). Using Siglec-H and NK1.1 markers, we unambigu-
ously dissected B220    CD11c     cells and found that PDCs are the only professional inter-
feron (IFN)-      –  producing cells within this heterogeneous population. In contrast, B220   
CD11c    NK1.1     cells are a discrete NK cell subset capable of producing higher levels of 
IFN-     than conventional NK cells. Unlike DCs, only a minute fraction of B220    CD11c   
NK1.1     cells in the spleen expressed major histocompatibility complex class II ex vivo or 
after stimulation with CpG. Consistent with being a NK cell subset, B220    CD11c    NK1.1     
cells depended primarily on interleukin 15 and common cytokine receptor      chain signaling 
for their development. In terms of function, expression of distinctive cell surface receptors, 
and location in lymphoid organs, NK1.1    B220    CD11c     appear to be the murine equivalent 
of human CD56  bright   NK cells. 2562 B220    CD11C   NK1.1     CELLS BELONG TO THE NK CELL LINEAGE | Blasius et al.
capable of producing copious amounts of IFN-     (up to 10 ng/ml 
from 10  5   cells). In contrast, Siglec-H        NK1.1      and Siglec-
H        NK1.1         cells did not produce detectable levels of IFN-     . 
Collectively, these results provide evidence of   phenotypic and 
their relationship, development, and functions. Three PDC-
specifi  c cell surface molecules have been recently identifi  ed. 
Ly49Q and bone marrow stromal antigen 2 are both specifi  c for 
PDCs under steady-state conditions but are up-regulated by 
type I IFNs and IFN-      during viral infections or after adminis-
tration of Toll-like receptor (TLR) ligands (  8  –  10  ). However, 
Siglec-H appears to be specifi  c for PDCs under steady-state and 
stimulatory conditions (  11  –  13  ). In this study, we found that the 
heterogeneous population of B220     CD11c      cells can be re-
solved into three distinct cell subsets based on the expression of 
Siglec-H and NK1.1. Siglec-H     NK1.1         cells are the only true 
PDCs that produce IFN-      in response to TLR9 stimula-
tion and require FLT3L for development. A second Siglec-
H        NK1.1         subset mostly consists of CD19      Ig      B cells. Finally, 
Siglec-H        NK1.1      cells correspond to IKDCs. In contrast to pre-
vious reports, we found that these cells do not produce IFN-      
and do require the      c and IL-15 for development. Thus, these 
cells belong to the NK cell lineage. We detected MHC class II 
only on a very small percentage of B220     CD11c     NK1.1      NK 
cells in the spleen. Although in lymph nodes the percentage 
of MHC class II      NK cells was markedly higher than in 
the spleen, MHC class II expression did not correlate with 
CD11c and/or B220 expression. Importantly, we found that 
B220     CD11c     NK1.1      NK cell phenotype and function re-
semble those of human CD56  bright   NK cells, which are present 
in lymphoid organs and eff  ectively produce IFN-     . We con-
clude that B220     CD11c     Siglec-H        NK1.1      cells have no 
marked functional or developmental overlap with PDCs or 
DCs, belong to the NK cell lineage, and include a mature NK 
cell subset specialized in cytokine secretion. 
    RESULTS AND DISCUSSION   
  Heterogeneity of B220    CD11c     cells in lymphoid organs 
  To investigate the nature of B220     CD11c      cells in lymphoid 
organs, we analyzed Siglec-H and NK1.1 expression within 
these cells. Siglec-H is a PDC marker that, in contrast to bone 
marrow stromal antigen 2 (120G8, 927, and PDCA1) and 
Ly49Q, maintains specifi  city after viral infection or stimu-
lation with TLR ligands (  8, 10  –  12  ). NK1.1 is expressed on 
conventional NK cells and a recently described hybrid cell 
type, termed IKDC, which appears to share functional fea-
tures with NK cells, PDCs, and DCs (  2, 3  ). B220     CD11c      
cells in the spleen, lymph nodes, and bone marrow included 
three distinct subsets: (a) a Siglec-H     NK1.1         subset that cor-
responds to PDC; (b) a Siglec-H        NK1.1      subset that fulfi  lls 
the defi  nition of IKDC (B220     CD11c     NK1.1      cells); and 
(c) a Siglec-H        NK1.1         subset (  Fig. 1 A  ).   This latter subset 
was highly represented in the spleen and lymph node, where 
it mostly included mature CD19     IgM      B cells (not depicted). 
In bone marrow, this subset was less abundant and exhibited 
further heterogeneity, as     40  –  50% of the cells expressed 
CD19 and IgM (  Fig. 1 B  ). To determine which cell subset is 
capable of producing IFN-      in response to TLR9 stimulation, 
we sorted the three cell subsets and measured IFN-      released in 
culture supernatant after stimulation with CpG oligodeoxyribo-
nucleotide (ODN). Siglec-H     NK1.1         cells were the only cells 
  Figure 1.     Heterogeneity of B220    CD11c     cells in lymphoid 
organs. (A) Four-color analysis of spleen, lymph node, and bone marrow 
cells. B220    CD11c     double-positive cells (gate R2) were divided into three 
subsets based on expression of Siglec-H and NK1.1. One subset expresses 
Siglec-H, a marker of PDCs. A second subset expresses NK1.1. A third sub-
set is Siglec-H       NK1.1        and includes mature B cells in the spleen and 
lymph nodes (not depicted). Percentages of each subset are indicated. 
Each spleen contained 5  –  8       10 7   cells. From two femurs of an 8  –  16-wk-old 
mouse we recovered 2  –  4       10 7   bone marrow cells. A Gate (R1) was applied 
on live cells based on FSC and SSC. FL-1/FL-2 double-positive autofl  uorescent 
cellular debris was removed from the analysis by an exclusion gate (R3). 
(B) The Siglec-H       NK1.1        subset displays further heterogeneity in bone 
marrow. About 40  –  55% of the cells in different experiments are CD19    IgM     
B cells. However,     40  –  50% of the remaining cells do not express lineage 
markers. Plots shown in A and B are representative of at least three to 
four separate experiments with concordant results. (C) Siglec-H    NK1.1      , 
NK1.1    Siglec-H       , and Siglec-H       NK1.1        were FACS sorted from the 
spleens of C57BL/6 mice, and identical numbers (10  5  ) of cells were stimu-
lated with CpG ODN 2216. After overnight culture, IFN-      secretion  was 
determined in culture supernatants. Results are representative of three 
independent  experiments.   JEM VOL. 204, October 29, 2007  2563
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and Siglec-H      cells (  Fig. 2 A  ).   By using CD11c and B220 
antibodies conjugated to allophycocyanin and PerCP-Cy5.5 
for sorting, we were able to further characterize the two cell 
populations using FITC- and RPE-conjugated antibodies. 
B220     CD11c      cells were highly enriched in cells coexpress-
ing the TNF receptor family member CD27, which is the 
receptor for CD70, and the integrin      M (CD11b) (  Fig. 2 B  ). 
They also included high percentages of cells expressing the 
growth factor receptor c-kit (CD117), but not the IL-7R      
chain (CD127), which was recently reported as a marker for 
functional heterogeneity within B220     CD11c      cells in lym-
phoid organs and defi  ne the Siglec-H     NK1.1         cell subset as 
the professional IFN-      producer cell type. 
  Siglec-H       NK1.1     cells are endowed with high IFN-     
secretion capacity 
  To compare B220     CD11c      NK1.1      cells with   conventional 
NK cells, we enriched DX5      cells from spleens by magnetic 
positive selection and sorted B220     CD11c      and B220      
  CD11c  low/       cells, excluding contaminating CD3     , CD19     , 
  Figure 2.     B220    CD11c    NK1.1     cells are enriched in CD27    CD11b     cells endowed with high IFN-      secretion capacity. (A) Splenic DX5      cells 
were preenriched by DX5 MACS separation. Cells were then stained with a combination of FITC-conjugated anti-CD3, anti-CD19, and  anti – Siglec-H 
antibodies to remove contaminating T cells, B cells, and PDCs (R2). In addition, they were stained with allophycocyanin-conjugated CD11c and PerCP-
Cy5.5 – conjugated  B220.  B220   CD11c     (R3) and B220       CD11c low/       (R4) cells were FACS sorted at high purity. One sorting experiment representative of 
seven is illustrated. (B) Sorted B220    CD11c     cells (top panels) are highly enriched in CD11b    CD27     (75  –  90% in different experiments) and c-kit     
(CD117, 35  –  45% in different experiments) but not in IL-7R         (CD127) NK cells. One experiment representative of three is shown. (C) B220    CD11c    
cells (top panels) are enriched in Ly49D      NK cells, whereas other Ly49 family members have a similar distribution between the two subsets. 2B4 is 
slightly higher in B220    CD11c     cells. One experiment representative of three is shown. (D) B220    CD11c     NK cells express more L-selectin than 
B220       CD11c low/       NK cells. (E) B220    CD11c     NK cells kill YAC cells as effi  ciently as B220       CD11c low/       NK cells. Killing is partially blocked by an anti-
NKG2D antibody in both subsets. One of two experiments with identical results is shown. (F) B220    CD11c     cells produce higher amounts of IFN-      than 
B220       CD11c low/       NK cells in response to PMA/ionomycin, IL-12 plus IL-18, and CpG ODN1826 and ODN1668. 2       10 4   cells for each condition and sub-
set were assayed in 100      l of cell culture medium. The supernatants were analyzed after overnight culture. (G) TNF-      was measured after stimulation 
with PMA/ionomycin and CpG, as described above. No TNF-      secretion was detected upon stimulation with IL-18 plus IL-12. In E and F, one of two 
experiments with identical results is shown.     2564 B220    CD11C   NK1.1     CELLS BELONG TO THE NK CELL LINEAGE | Blasius et al.
NK cells of thymic origin (  14  ). In contrast, B220        CD11c  low/       
cells contained a high percentage of CD11b     CD27         NK 
cells, few CD117      cells (5  –  8% in diff  erent experiments), and 
some CD127      cells. B220     CD11c      cells also exhibited a 
unique repertoire of activating and inhibitory receptors. As 
compared with B220        CD11c  low/      , they contained two- to 
threefold more cells expressing the activating receptor Ly49D, 
which recognizes both allogeneic and xenogenic MHC class I 
(  15, 16  ), and expressed slightly higher levels of 2B4 (  Fig. 2 C  ). 
B220     CD11c      cells also expressed higher level of the lym-
phocyte homing molecule L-selectin (CD62L) (  Fig. 2 D  ). 
Several other Ly49 family receptors were similarly expressed 
by the two subsets, with the exception of a slight but re-
producible increase in the percentage of Ly49C/I      cells 
within the B220        CD11c  low/       population (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20070991/DC1). 
The receptors NKG2A/C/E and the integrin CD49 (DX5) 
were also equally expressed (Fig. S1 and Fig. 2). 
  Comparison of the cytolytic capacity of B220     CD11c      
and B220        CD11c  low/       NK cells revealed that these NK cell 
subsets killed the classical target YAC-1 ex vivo equally well 
(  Fig. 2 E  ). Reduction of YAC-1 killing by an anti-NKG2D 
antibody demonstrated that cytotoxicity was partly mediated 
by the activating receptor NKG2D in both subsets. We also 
compared the ability of the two cell subsets to secrete cyto-
kines in response to diff  erent activating stimuli. Both subsets 
produced IFN-      in response to PMA/ionomycin and IL-12/
IL-18 (  Fig. 2 F  ), although B220     CD11c      cells produced 
two- to fourfold more IFN-      than B220        CD11c  low/       cells. 
In addition, both cell subsets produced IFN-      and TNF-      
in response to CpG stimulation, although B220     CD11c      
cells were again much more effi   cient than B220     CD11clow/      
cells (  Fig. 2, F and E  , and Fig. S1). Collectively, these results 
demonstrate that B220     CD11c      NK cells are enriched in 
CD27     CD11b      NK cells that secrete cytokines more eff  ec-
tively than conventional B220     CD11clow/      NK cells, although 
they are equivalent in lytic capacity. 
  A minor subset of B220    CD11c    NK1.1     cells express 
MHC class II 
  It has been proposed that B220     CD11c     NK1.1      cells are 
related to DCs because they express MHC class II (  2, 3  ). 
To determine whether MHC class II is a unique feature of 
B220     CD11c     NK1.1      cells, we assessed MHC class II 
expression on B220     CD11c      and B220        CD11c  low/       NK cells 
  Figure 3.     MHC class II expression in NK cells sorted from the 
spleen and lymph nodes. (A) Sorted B220    CD11c     and  B220      CD11c low/      
splenic cell subsets were stained with anti-NK1.1 and anti  –  I-A/I-E, either 
ex vivo or after overnight culture with 5     g/ml  IFN-    . Between 1 and 5% 
of B220    CD11c     cells expressed MHC class II in at least six different ex-
periments performed. IFN-      did not induce a signifi  cant up-regulation of 
MHC class II. One of two experiments with identical outcome is shown. 
Notably, B220    CD11c     cells reproducibly expressed slightly higher levels 
of NK1.1. (B) CpG stimulation slightly increased the percentage of MHC 
class II      cells within the B220    CD11c     cell subset. CpG ODN1668 was 
more effi  cient than CpG ODN1826; however, the increment in MHC class II     
cells never exceeded a threefold increase. One of two experiments with 
similar results is illustrated. (C) Inguinal and laterocervical lymph nodes 
and spleens of RAG2      /      mice were dissected, and DX5      cells were en-
riched by magnetic selection. Cells were stained with B220, CD11c, NK1.1, 
and MHC class II. Gates were applied on the B220    CD11c   NK1.1     and 
B220       CD11c low/     NK1.1     subsets as represented in Fig. 2 A. Although 
lymph nodes exhibit higher percentages of MHC class II      NK1.1 cells than 
spleen, MHC class II expression does not correlate with B220 and/or 
CD11c. One of three experiments with identical results is shown.     JEM VOL. 204, October 29, 2007  2565
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Siglec-H     NK1.1         PDCs were selectively reduced in the spleen 
and lymph nodes of these mice (  Fig. 4 A   and Fig. S3, which 
is available at http://www.jem.org/cgi/content/full/jem
.20070991/DC1).   On the contrary, the presence of NK1.1    
Siglec-H         was minimally aff  ected, suggesting that B220    
CD11c     NK1.1      cells do not follow a PDC/DC developmental 
pathway. Although in the bone marrow the relative percentage 
of Siglec-H     NK1.1         was only partly reduced, and that of 
NK1.1     Siglec-H         cells was conserved, all B220     CD11c      cells 
were severely reduced (    10  –  15-fold in diff  erent mice). There-
fore, the total numbers of bone marrow Siglec-H     NK1.1         and 
NK1.1     Siglec-H         cells are also reduced (Fig. S3). 
  It has been shown that IL-2R            /       mice lack B220    
CD11c     NK1.1      cells (  3  ). IL-2R      is the receptor for IL-15, 
a cytokine required for NK cell development (  20  ). Thus, we 
examined B220     CD11c      heterogeneity in IL-15       /       mice 
and found that B220     CD11c     NK1.1      cells were severely 
reduced, whereas PDCs and Siglec-H        NK1.1         cells were 
not particularly aff  ected (  Fig. 4 B   and Fig. S3). This result 
corroborated the hypothesis that the development of B220    
CD11c     NK1.1      cells depends on IL-15/IL-15R signaling. 
This conclusion was at odds with a previous report showing 
that B220     CD11c     NK1.1      cells do not develop in mice lack-
ing      c, which is required for IL-15R signaling. To address 
sorted from the spleen. An antibody specifi  c for I-A and I-E de-
tected MHC class II on few B220     CD11c      NK cells (between 
1 and 5%) (  Fig. 3 A   and Fig. S2, which is available at http://
www.jem.org/cgi/content/full/jem.20070991/DC1).   Treat-
ment of sorted cells with IFN-     , a known inducer of MHC 
class II, did not result in a marked increase of MHC expression 
(  Fig. 3 A  ). However, stimulation of sorted cells with CpG 1668 
induced approximately a twofold increase in the percentage of 
MHC class II      cells (  Fig. 3 B  ). We conclude that very few 
spleen NK1.1     B220     CD11c      cells express MHC class II, and 
this expression appears to be controlled by an IFN-       –  indepen-
dent TLR-dependent mechanism. In peripheral lymph nodes 
many more NK1.1      NK cells expressed cell surface MHC 
class II than in the spleen. However, MHC class II expression 
did not correlate with CD11c and B220 expression (  Fig. 3 C  ). 
  B220    CD11c    NK1.1     cells belong to the NK cell lineage 
  To determine whether B220     CD11c     NK1.1      cells follow 
DC or NK cell developmental pathways, we assessed which 
cytokines are required in vivo for B220     CD11c     NK1.1      
development. FLT3L is a cytokine essential for the develop-
ment of classical DC subsets and PDC (  17, 18  ), whereas NK 
cells are less FLT3L dependent (  19  ). Analysis of heterogeneity 
of B220     CD11c      cells in FLT3L-defi  cient mice showed that 
  Figure 4.     B220    CD11c    NK1.1     cell development is largely FLT3-L independent but requires IL-15. Siglec-H    NK1.1      ,  Siglec-H      NK1.1   ,  and 
Siglec-H       NK1.1        subsets in the spleen, lymph nodes, and bone marrow of FLT3L      /      mice  or  IL-15 – defi  cient mice were gated within the B220    CD11c    
population as described in Fig. 1. (A) In the absence of FLT3L, Siglec-H      PDCs are signifi  cantly reduced in the spleen and lymph nodes. Although in bone 
marrow the percentage of Siglec-H      cells was only partly reduced, and that of NK1.1      cells was not affected, the entire B220    CD11c     population  was 
severely reduced (    10  –  15-fold). Percentages of each subset are indicated. An FLT3L      /      spleen contained 3.5  –  7       10 7   cells. From two femurs of an 8  –  16 
wk-old FLT3L      /      mouse we recovered 1.5  –  3       10 7   bone marrow cells. (B) Lack of IL-15 resulted in a severe decrease of the B220    CD11c   NK1.1     subset 
in all the lymphoid organs analyzed. Percentages of each subset are indicated. An IL-15      /      spleen  contained  4.5 – 7.5       10 7   cells. From two femurs of an 
8 – 16-wk-old  IL-15     /      mice we recovered 2.5  –  4       10 7   bone marrow cells. Data presented in this fi  gure were acquired in parallel with data from the B6 WT 
mice presented in Fig. 1 and are representative of at least four separate experiments with two mice for each genotype.     2566 B220    CD11C   NK1.1     CELLS BELONG TO THE NK CELL LINEAGE | Blasius et al.
precursor cell and what the function of these cells is in vivo 
remains to be determined. 
  Concluding remarks 
  Dissection of the heterogeneous B220     CD11c      cell popula-
tion has allowed us to address important questions concerning 
the nature of B220     CD11c     NK1.1      cells as well as possible 
functional overlaps with PDCs and DCs. We found that PDCs 
but not B220     CD11c     NK1.1      cells produce IFN-      upon 
stimulation with CpG. We also demonstrated that FLT3L is 
required for normal PDC numbers in the bone marrow and 
peripheral lymphoid organs, but it is not essential for B220    
CD11c     NK1.1      cell development. Therefore, PDCs and 
B220     CD11c     NK1.1      cells are distinct with respect to secre-
tion of type I IFN and developmental requirements. 
  Are B220     CD11c      NK cells any diff  erent from other NK 
cells? We found that most B220     CD11c      are CD27     CD11b     . 
A previous study showed that CD27 is a marker for immature 
NK cells as well as a subset of mature NK cells that home to 
secondary lymphoid organs and have highly cytolytic and 
IFN-      secretion capacity. In contrast, mature CD11b     CD27         
NK cells home to peripheral tissues and have limited eff  ector 
functions (  21  ). Our results demonstrate that CD27     CD11b      
NK cells are highly enriched within the B220     CD11c      NK 
population. Moreover, their phenotypes and functions are 
this discrepancy, we analyzed RAG2       /       and RAG2       /           c       /       
mice. PDCs were present in both RAG2       /       and RAG2       /       
   c       /       mice (  Fig. 5   and Fig. S3).   Siglec-H        NK1.1         cells were 
almost absent in the spleens and lymph nodes of RAG2       /       
and RAG2       /           c       /       mice, corroborating the notion that this 
subset contains mainly B cells. In contrast, B220     CD11c    
NK1.1      cells were dramatically reduced in the lymphoid 
organs of RAG2       /           c       /       but not RAG2       /       mice (  Fig. 5   
and Fig. S3). 
  Notably, a few residual NK1.1      cells were present in the 
spleens of RAG2       /           c       /       mice. To defi  ne the nature of 
these cells, we enriched DX5      cells from RAG2       /           c       /       
spleens by positive selection. Few live cells (0.5  –  1       10  4  /
spleen) copurifi  ed with cellular debris (Fig. S4 A, available at 
http://www.jem.org/cgi/content/full/jem.20070991/DC1). 
Only 5  –  10% of these cells were CD3        CD19        NK1.1      and 
coexpressed CD11c and B220, and to some extent also MHC 
class II ex vivo (Fig. S4 B). Collectively, our results indicate 
that most B220     CD11c     NK1.1      cells require IL-15/IL-15R 
signaling for their development, supporting the notion that 
these cells belong to NK cell lineage. However, very few 
B220     CD11c     NK1.1      cells do develop in the absence of      c. 
The number of cells recovered from RAG2       /           c       /       spleens 
was     1% of the B220     CD11c     NK1.1      cells purifi  ed from 
WT mice. Whether these cells are a novel cell type or a rare 
  Figure 5.     Development of B220    CD11c    NK1.1     cells requires      c signaling. Siglec-H    NK1.1      ,  Siglec-H      NK1.1    , and Siglec-H       NK1.1        subsets 
were evaluated in the spleen, lymph nodes, and bone marrow of RAG2      /      and  RAG2     /       c     /      double-defi  cient mice. (A) Percentages of Siglec-H       NK1.1       
cells were strongly reduced in RAG2      /      mice, consistent with their B cell identity. Siglec-H    NK1.1        and  Siglec-H      NK1.1     were both present. Percentages 
of each subset are indicated. Each RAG2      /      spleen contained 1.5  –  3       10 7   cells. From two femurs of a RAG2      /      mouse we recovered 1.5  –  4       10 7   bone 
marrow cells. (B) B220    CD11c   NK1.1     cells in the spleen, lymph nodes, and bone marrow of RAG2      /       c     /      mice were dramatically reduced. Each 
RAG2      /       c     /      spleen contained 1  –  2.5       10 7   cells. From two femurs of a RAG2      /       c     /      mouse we recovered 1  –  2.5       10 7   bone marrow cells. Data pre-
sented in this fi  gure were acquired in parallel with data from the B6 WT mice presented in Fig. 1 and are representative of at least three separate experi-
ments with two mice for each genotype.     JEM VOL. 204, October 29, 2007  2567
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  MATERIALS AND METHODS 
  Reagents and mice.     C57BL/6 mice were purchased from The Jackson 
Laboratory. Mice lacking FLT3L, IL-15, or RAG-2 were purchased from 
Taconic Farms. Mice doubly defi  cient in RAG-2 and common cytokine 
receptor      c mice were provided by W.M. Yokoyama and R.D. Schreiber 
(Washington University, St. Louis, MO). All animal studies were approved 
by the Washington University animal studies committee. Antibodies against 
CD11b, CD11c, CD19, NK1.1, B220, CD3, Ly49-A, Ly49-D, Ly49-C/I, 
CD27, 2B4, CD62L, DX5, NKG2A/C/E, and I-A/I-E were purchased 
from BD Biosciences. Antibodies against Ly49C/I/F/H and CD127 were 
purchased from eBioscience. The anti  –  Siglec-H antibody was described pre-
viously (  13  ). Sorting was performed on a MoFlo cell sorter (DakoCytomation) 
or a FACSVantage (BD Biosciences). Flow cytometry analysis was performed 
on a FACSCalibur or FACScan (BD Biosciences). Data were analyzed using 
the CELLQuest Pro software (BD Biosciences). 
  Identifi  cation, isolation, and culture of cell subsets.     Mouse spleen and 
lymph nodes were mechanically disrupted and digested with collagenase D 
(Sigma-Aldrich). Splenocytes and bone marrow were treated with red blood 
cell lysing buff  er (Sigma-Aldrich). Cell suspensions were fi  ltered and treated 
with FcR blocking antibody before staining. To assay for type I IFN pro-
duction, sorted cell populations were cultured for 18 h at 10  6   cells/ml and 
stimulated with CpG ODN2216 at 10      g/ml. Cell culture supernatants 
were assayed for IFN-      production by ELISA (PBL Interferonsource). To 
FACS sort NK cell subsets, DX5      cells were preenriched by magnetic posi-
tive selection with DX5 microbeads (Miltenyi Biotec). Cytotoxicity was 
measured by standard chromium release assay. To assay for IFN-      and TNF-      
production, 2       10  4   cells were stimulated overnight with IL-2, IL-12 
(1 ng/ml; PeproTech), IL-18 (10 ng/ml; PeproTech), PMA (10       7   M; Sigma-
Aldrich), ionomycin (0.5      g/ml; Sigma-Aldrich), and CpG ODN1826 and 
CpG ODN1668 (12      g/ml; QIAGEN) in 100      l of complete medium. 
Supernatants were collected and cytokines measured by BD Cytometric 
Bead Arrays (mouse infl  ammation kit and mouse Th1/Th2 kit). 
  Online supplemental material.     Fig. S1 shows expression of NK cell re-
ceptors and CpG-induced IFN-      production in B220     CD11c      and B220       
CD11c  low/       NK cells. Fig. S2 shows expression of MHC class II and CD122 
on B220     CD11c      and B220        CD11c  low/       NK cells. Fig. S3 shows absolute 
numbers of B220     CD11c      cell subsets in the spleen and bone marrow of 
WT, FLT3-L       /      , IL-15       /      , RAG2       /      , and RAG2       /           c       /       mice. Fig. S4 
shows characterization of DX5      cells from the spleen of RAG2       /           c       /       
mice. The online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20070991/DC1. 
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